Search

shutterstock_2261453831(1) (1)

Announcements

Announcements

HOMEWhat’s NewAnnouncements

2025.May.12

Announcement of change of Chief Scientific Officer

2025.May.12

OBI announces OBI-833 termination and refocuses resources on ADC development

2025.May.06

Announcement on behalf of Amaran of not Distributing Dividends of 2024

2025.May.06

Announcement on behalf of Amaran that the BOD resolved to convene the 2025 Annual General Shareholders' Meeting

2025.May.01

OBI-902 TROP2 ADC has been granted by US FDA to proceed to Phase I/II human clinical trial

2025.Apr.30

Announcement for the expected date of the Board of Directors Meeting for 2025Q1 consolidated financial report is 2025/05/12

2025.Apr.23

To announce the press release for material information in a press conference

2025.Apr.23

OBI decided to terminate OBI-822 Phase 3 study based on DSMB's recommendation and to redirect resources towards ADCs development

2025.Apr.22

Announcement on behalf of OBIGEN of Establishment of the Remuneration Committee and Appointment of the First-Term Members

2025.Apr.22

Announcement on behalf of OBIGEN the new replacement of its spokesperson and acting spokesperson

News

Latest News

Events

Latest events